G01N 2800/046
Thyroid disorders
G01N2800/046 (Thyroid disorders) appears on 54 US grants and 88 published applications in this corpus.
Search patents in G01N- Granted patents
- 54
- Published applications
- 88
- Assignees
- 61
- Inventors
- 200
- Latest grant
- 14 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 2 | 3 |
| 2005 | 1 | 1 |
| 2006 | 2 | 3 |
| 2007 | 1 | 2 |
| 2008 | 0 | 5 |
| 2009 | 0 | 1 |
| 2010 | 3 | 7 |
| 2011 | 4 | 6 |
| 2012 | 3 | 6 |
| 2013 | 4 | 3 |
| 2014 | 1 | 5 |
| 2015 | 4 | 10 |
| 2016 | 4 | 3 |
| 2017 | 3 | 6 |
| 2018 | 2 | 4 |
| 2019 | 3 | 5 |
| 2020 | 5 | 2 |
| 2021 | 0 | 3 |
| 2022 | 3 | 1 |
| 2023 | 2 | 1 |
| 2024 | 1 | 5 |
| 2025 | 0 | 3 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for detecting autoantibodies14 Jul 2026US 12,681,016 B2Ortho-Clinical Diagnostics, Inc.
- Methods for differentiating destructive thyroiditis from other pathological conditions10 Feb 2026US 12,546,788 B2Aska Pharmaceutical Co., Ltd.
- Compositions and methods for detecting autoantibodies24 Dec 2024US 12,174,185 B2Quidel Corporation
- Thyroid peroxidase autoantibody immunoassay5 Dec 2023US 11,835,518 B2Siemens Healthcare Diagnostics Inc.
- Method and reagent for measuring thyroglobulin26 Sep 2023US 11,768,209 B2Fujirebio Inc.
- Molecules for controlling autoimmune response18 Jun 2026US 2026/0167684 A1Merida Biosciences, Inc.
- Ig-like fusion proteins for treating graves disease11 Dec 2025US 2025/0376502 A1Canopy Immuno-Therapeutics Ltd.
- Immunoassay for thyroglobulin and kit therefor8 May 2025US 2025/0147029 A1Advanced Life Science Institute, Inc.
- Anti-thyroglobulin Antibody, Kit and Use Thereof30 Jan 2025US 2025/0034236 A1Hytest Ltd.
- Novel predictive biomarkers for secondary autoimmunity after lymphocyte depleting therapy1 Aug 2024US 2024/0254556 A1Genzyme Corporation
Most cited
By later US patents
- Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism32US 7,056,655 B2Scantibodies Laboratory, Inc. · 2006
- DNA and vectors encoding the parathyroid hormone receptor, transformed cells, and recombinant production of PTHR proteins and peptides26US 5,494,806 AThe General Hospital Corporation · 1996
- Thyroglobulin quantitation by mass spectroscopy26US 9,915,663 B2Quest Diagnostics Investments Incorporated · 2018
- Thyroglobulin quantitation by mass spectroscopy23US 9,012,394 B2Quest Diagnostics Investments Incorporated · 2015
- Thyroglobulin quantitation by mass spectroscopy22US 9,580,740 B2Quest Diagnostics Investments Incorporated · 2017